242 related articles for article (PubMed ID: 23967267)
1. Loss of the anorexic response to systemic 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside administration despite reducing hypothalamic AMP-activated protein kinase phosphorylation in insulin-deficient rats.
Vitzel KF; Bikopoulos G; Hung S; Curi R; Ceddia RB
PLoS One; 2013; 8(8):e71944. PubMed ID: 23967267
[TBL] [Abstract][Full Text] [Related]
2. Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity.
Gaidhu MP; Frontini A; Hung S; Pistor K; Cinti S; Ceddia RB
J Lipid Res; 2011 Sep; 52(9):1702-11. PubMed ID: 21737753
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats.
Vitzel KF; Bikopoulos G; Hung S; Pistor KE; Patterson JD; Curi R; Ceddia RB
PLoS One; 2013; 8(4):e62190. PubMed ID: 23620811
[TBL] [Abstract][Full Text] [Related]
4. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
Cuthbertson DJ; Babraj JA; Mustard KJ; Towler MC; Green KA; Wackerhage H; Leese GP; Baar K; Thomason-Hughes M; Sutherland C; Hardie DG; Rennie MJ
Diabetes; 2007 Aug; 56(8):2078-84. PubMed ID: 17513706
[TBL] [Abstract][Full Text] [Related]
5. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans.
Steinberg GR; McAinch AJ; Chen MB; O'Brien PE; Dixon JB; Cameron-Smith D; Kemp BE
J Clin Endocrinol Metab; 2006 Sep; 91(9):3592-7. PubMed ID: 16822822
[TBL] [Abstract][Full Text] [Related]
6. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
7. Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep.
Laker RC; Henry BA; Wadley GD; Clarke IJ; Canny BJ; McConell GK
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R511-8. PubMed ID: 21148475
[TBL] [Abstract][Full Text] [Related]
8. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleoside prevents leucine-stimulated protein synthesis in rat skeletal muscle.
Pruznak AM; Kazi AA; Frost RA; Vary TC; Lang CH
J Nutr; 2008 Oct; 138(10):1887-94. PubMed ID: 18806097
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminoimidazole-4-carboxamide ribonucleotide prevents fat gain following the cessation of voluntary physical activity.
Ruegsegger GN; Sevage JA; Childs TE; Grigsby KB; Booth FW
Exp Physiol; 2017 Nov; 102(11):1474-1485. PubMed ID: 28786140
[TBL] [Abstract][Full Text] [Related]
10. Epinephrine and AICAR-induced PGC-1α mRNA expression is intact in skeletal muscle from rats fed a high-fat diet.
Frier BC; Wan Z; Williams DB; Stefanson AL; Wright DC
Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1772-9. PubMed ID: 22496244
[TBL] [Abstract][Full Text] [Related]
11. AICAR and Compound C regulate food intake independently of AMP-activated protein kinase in lines of chickens selected for high or low body weight.
Xu P; Siegel PB; Denbow DM
Comp Biochem Physiol A Mol Integr Physiol; 2011 Aug; 159(4):401-12. PubMed ID: 21530673
[TBL] [Abstract][Full Text] [Related]
12. AICAR treatment for 14 days normalizes obesity-induced dysregulation of TORC1 signaling and translational capacity in fasted skeletal muscle.
Drake JC; Alway SE; Hollander JM; Williamson DL
Am J Physiol Regul Integr Comp Physiol; 2010 Dec; 299(6):R1546-54. PubMed ID: 20844264
[TBL] [Abstract][Full Text] [Related]
13. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
Perrin C; Knauf C; Burcelin R
Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
[TBL] [Abstract][Full Text] [Related]
15. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes.
Gaidhu MP; Perry RL; Noor F; Ceddia RB
Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641
[TBL] [Abstract][Full Text] [Related]
16. Activation of insulin signaling and energy sensing network by AICAR, an AMPK activator in insulin resistant rat tissues.
Radika MK; Anuradha CV
J Basic Clin Physiol Pharmacol; 2015 Nov; 26(6):563-74. PubMed ID: 26124049
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
18. Chronic activation of central AMPK attenuates glucose-stimulated insulin secretion and exacerbates hepatic insulin resistance in diabetic rats.
Park S; Kim DS; Kang S; Shin BK
Brain Res Bull; 2014 Sep; 108():18-26. PubMed ID: 25149877
[TBL] [Abstract][Full Text] [Related]
19. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
[TBL] [Abstract][Full Text] [Related]
20. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
